e-learning
resources
Munich 2006
Tuesday 05.09.2006
The challenges of managing asthma in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Medical personnel‘s ability to use pressurized metered dose inhaler (pMDI) in India
S. S. Salvi, R. Kesarwani, A. Raghupathy, B. B. Brashier, S. Valsa, S. Gaikwad, D. R. Joshi, S. V. Ghorpade (Pune, India)
Source:
Annual Congress 2006 - The challenges of managing asthma in primary care
Session:
The challenges of managing asthma in primary care
Session type:
Oral Presentation
Number:
3366
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. S. Salvi, R. Kesarwani, A. Raghupathy, B. B. Brashier, S. Valsa, S. Gaikwad, D. R. Joshi, S. V. Ghorpade (Pune, India). Medical personnel‘s ability to use pressurized metered dose inhaler (pMDI) in India. Eur Respir J 2006; 28: Suppl. 50, 3366
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations?
Source: Eur Respir J 2002; 19: 928-935
Year: 2002
Resistance to resistance
Source: Annual Congress 2007 - Primary care: delivering the goods: "inhaled therapies"
Year: 2007
Inhaler choice in primary practice
Source: Eur Respir Rev 2005; 14: 117-122
Year: 2005
Mechanisms of exacerbation of respiratory symptoms in patients with COPD
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Inhalation characteristics of asthmatic children (child), adults asthmatics (adult) and chronic obstructive pulmonary disease patients when they inhale through a spiromax dry powder inhaler (DPI)
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009
NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006
A comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a double-blind, efficacy and safety study in Chinese adults with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 213s
Year: 2006
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 74-81
Year: 2003
Inhaler treatment options in COPD
Source: Eur Respir Rev 2005; 14: 102-108
Year: 2005
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 217-224
Year: 2002
Aerosolotherapy in stable chronic obstructive pulmonary disease (COPD) – common inhalers use ability and usefulness of PIF measurement in choice of inhalers
Source: Annual Congress 2007 - Managing COPD in primary care
Year: 2007
Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids
Source: Annual Congress 2006 - COPD therapy
Year: 2006
The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008
Patient preference for and satisfaction with inhaler devices
Source: Eur Respir Rev 2005; 14: 109-116
Year: 2005
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
Source: Eur Respir J 2002; 19: 209-216
Year: 2002
Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
Source: Eur Respir J 2003; 21: 68-73
Year: 2003
Pharmacological characterisation of indacaterol (QAB149), a novel once-daily inhaled β
2
-agonist, on small airways in human and rat lung slices
Source: Annual Congress 2006 - Novel treatments for asthma
Year: 2006
Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001
Improving inhaler use in COPD and the role of patient preference
Source: Eur Respir Rev 2005; 14: 85-88
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept